Dr. Olaf Valverde Mordt

Dr. Olaf Valverde Mordt works at DNDi as Medical Manager in human African trypanosomiasis drug development program since June 2009. Earlier he served as Country Coordinator for MdM in Indonesia (2006-08), has over 20 years of field humanitarian experience mostly with MSF in Latin America, Africa and Asia, including the MSF Access to Essential Medicines Campaign in Guatemala and Indonesia. Involved in malaria, HIV, cholera, vaccination, emergencies and other health issues. He participated in the initial steps of access to AIDS treatment in Central America. He was general Director of the Spanish section of MSF between 1995 and 1997. He faced human African trypanosomiasis in Uganda (1989), Angola (1995) and DR of Congo (2003). He is medical doctor trained in Madrid (1984), Diploma in Tropical Medicine in Barcelona in 1988 and he is MSc in Public Health in Developing Countries for the London School of Hygiene and Tropical Medicine since 1994.

Dr. Florent Mbo

Dr. Florent Mbo works at DNDi as an access and human African trypanosomiasis (HAT) platform coordinator since 2015. He has over 20 years of field experience as a GP, health district hospital medical director, head of health district, provincial coordinator of national sleeping sickness control program of Democratic Republic of Congo for over ten years. As an access and HAT platform coordinator, he is focusing on advocacy to African endemic countries to use news drugs by obtaining the authorization of use via Ministries of Health and training on new drugs use and pharmacovigilance (PV) within endemic countries in collaboration with WHO. He trained as a medical doctor in Kinshasa (1998), and received a MSc in tropical diseases control for Tropical Medicine Institute from Antwerp, Belgium in 2007. He also has two university certificates in health system research from Health public school (Free University of Brussels) in 2012 and health policy (Tropical Medicine Institute of Antwerp) in 2014 in Belgium.

Dr. Peter Steinmann

Dr. Peter Steinmann is a trained epidemiologist and public health specialist, and holds a habilitation (Associate professorship) in epidemiology at the University of Basel. He has a track record of epidemiological and implementation research and consultancy work related to neglected tropical diseases (NTDs), health system strengthening, project monitoring and public health in general in Africa, Asia and Brazil. He regularly teaches at the University of Basel, publishes in leading global health and tropical disease journals, and presents findings at international conferences. His main interest is the validation and uptake of innovations for NTD control programs, with a focus on soil-transmitted helminthiasis, schistosomiasis and leprosy. Within the Pediatric Praziquantel Consortium, Peter co-leads the Access sub-team and coordinates the contribution of Swiss TPH to the ADOPT implementation research program, with a focus on protocol rigor, scientific documentation and dissemination to policy makers, the scientific community and other stakeholders.

Dr. Khadija I. Yahya-Malima

Dr. Khadija Innocensia Yahya-Malima is a consultant epidemiologist with a nursing background, and is currently a lecturer at Muhimbili University of Health and Allied Health Sciences (MUHAS), Dar es Salaam, Tanzania. She has more than sixteen years of experience working with national, regional and international experts in academia; public health; health care systems; coordination, monitoring and promotion of health research to regulation of biomedical research and regulation of health care professionals. She has also served as a liaison and a technical advisor with international agencies in promoting the conduct of clinical trials and promoting innovations in health and evidence-based policy and decision making. Her interest in public health led her to work on the epidemiology of HIV and other STIs with a focus on community based preventive intervention research within rural remote areas of Tanzania, in the early phases of the epidemic and earned her a PhD from the University of Bergen, Norway. She is highly committed in contributing her skills and expertise in teams that deliver health care solutions to society.

Dr. Paul E. Kazyoba

Dr. Paul Erasto Kazyoba is a Chief Research Scientist and Director of Research Coordination and Promotion at the National Institute for Medical Research (NIMR), Tanzania. He holds a PhD (Phytomedicines) from the University of Fort Hare, South Africa, and MPhil (Med Chemistry) from the University of Botswana. Early in his career, he was involved in research focusing on drug discovery with a focus on tuberculosis and malaria. Currently, he is coordinating the implementation of the Access and Delivery Partnership (ADP) activities with an emphasis on implementation research. Working with Special programme for research and training in tropical diseases (TDR), Dr. Kazyoba is coordinating the projects on quantification of medicines, strengthening institutional capacity to adopt and deploy pediatric praziquantel formulation when it will be available, and strengthening the capacity of the country to adopt and implement the new WHO roadmap for eliminating NTDs 2021-2030.

Mr. Modeste Tezembong

Mr Tezembong is a health Procurement and Supply Chain Management Advisor with extensive experience in health commodities such as HIV/AIDS, TB, Malaria and NTD drugs. He is currently serving as the regional technical officer for NTD medicines supply chain management at WHO AFRO in the ESPEN project. Before joining ESPEN, he previously worked for EGPAF, UNICEF, IOM, MINUSCA, etc. on projects funded by UNITAID/WHO, USAID/CDC-PEPFAR, BMGF, CIFF, J&J, ECHO, etc. He has a master’s degree in logistics and strategic supply chain from Institut Universitaire de la Cote (IUC), and a post graduate diploma in global health procurement and supply chain management from Empower School of Health & Kent State University.

Ms. Margo Warren

Margo Warren is the Head of Policy for the Access to Medicine Foundation. She liaises with governments, private foundations and multilateral organisations that are actively working to improve global health and access to medicine in order to share the Foundation’s research findings and identify key opportunities for collaboration and change-making. She represents the Foundation on external advisory committees and task forces, with a consortium of partners including the WHO and other UN agencies. Prior to joining the Foundation, Margo worked for the Ministry of Health and Long-Term Care in Ontario, Canada, in strategic health policy. In her position at the Ministry, Margo led the development of new initiatives pertaining to improving access to medicine, health system strengthening, and capacity building. Margo has held various health research and policy positions focused on partnerships for development, improving access to care, and addressing the social determinants of health both in Canada and globally. Margo holds both a Bachelor’s degree and a Master's degree in international development with a focus on health policy. She was also featured on the most recent List of Canadian Women in Global Health, recognizing the achievements of established leaders in global health.

Mr. Shinichi Kohguchi

Sumitomo Mitsui Trust Asset Management Co., Ltd. Stewardship Promotion Department Senior Stewardship Officer. Engaged in stock analyst business (industry / company survey) mainly in the healthcare sector in Japan and the United States for more than 30 years since 1990. Since 2021, he has been promoting the resolution of ESG issues through dialogue with companies, and is working toward the realization of sustainable growth for companies and society as a whole.

Mr. Esteban Burrone

Esteban Burrone is the Head of Policy of the Medicines Patent Pool (MPP), an institution he contributed to setting up in 2010 to promote access to affordable essential medicines in low-and middle-income countries, through the licensing of key patents. As Head of Policy, Esteban works on prioritizing medicines for licensing and on developing partnerships with organizations and stakeholders, including governments, universities, intergovernmental organizations and civil society organizations. He is also a member of the Senior Management Team of the MPP. He has over 15 years of experience working in the field of intellectual property rights and access to medicines. Esteban holds a MSc. in Public Health from the London School of Hygiene and Tropical Medicines (LSHTM) and an MSc. in Development Studies from the London School of Economics.